Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters

Database
Language
Publication year range
1.
J Neuroimmunol ; 266(1-2): 43-8, 2014 Jan 15.
Article in English | MEDLINE | ID: mdl-24262701

ABSTRACT

To clarify the mechanism of action of an intravenous immunoglobulin (IVIG) preparation in chronic inflammatory demyelinating polyneuropathy, the effects of IVIG were investigated using an experimental autoimmune neuropathy model in the rat. IVIG significantly suppressed the progression of neurologic signs and sciatic nerve conduction velocity with the inhibition of inflammatory cell infiltration, mainly of macrophages, to the peripheral nerves. A significant suppressive effect on the expression of macrophage inflammatory protein 1-α (MIP-1α) was simultaneously observed in the nerves. These results suggest that IVIG is effective for inflammatory demyelinating polyneuropathy by inhibiting the chemotactic factor of macrophages.


Subject(s)
Chemokine CCL3/metabolism , Immunoglobulins, Intravenous/therapeutic use , Neuritis, Autoimmune, Experimental/drug therapy , Neuritis, Autoimmune, Experimental/physiopathology , Action Potentials/drug effects , Animals , CD3 Complex , Calcium-Binding Proteins/metabolism , Chemokine CCL3/genetics , Chemokines/metabolism , Disease Models, Animal , Freund's Adjuvant/toxicity , Male , Microfilament Proteins/metabolism , Myelin Sheath/pathology , Neural Conduction/drug effects , Neuritis, Autoimmune, Experimental/pathology , RNA, Messenger/metabolism , Rats , Rats, Inbred Lew , Reaction Time/drug effects , Sciatic Nerve/drug effects , Sciatic Nerve/metabolism , Sciatic Nerve/physiopathology , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL